Search Results

There are 7994 results for: content related to: Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2

  1. Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease

    Movement Disorders

    Volume 31, Issue 8, August 2016, Pages: 1192–1202, Connie Marras, Roy N. Alcalay, Chelsea Caspell-Garcia, Christopher Coffey, Piu Chan, John E. Duda, Maurizio F. Facheris, Rubén Fernández-Santiago, Javier Ruíz-Martínez, Tiago Mestre, Rachel Saunders-Pullman, Claustre Pont-Sunyer, Eduardo Tolosa, Bjorg Waro and the LRRK2 Cohort Consortium

    Version of Record online : 19 APR 2016, DOI: 10.1002/mds.26614

  2. Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 906–914, Dolores Vilas, Leslie M. Shaw, Peggy Taylor, Daniela Berg, Kathrin Brockmann, Jan Aasly, Connie Marras, Claustre Pont-Sunyer, José Ríos, Ken Marek and Eduardo Tolosa

    Version of Record online : 4 APR 2016, DOI: 10.1002/mds.26591

  3. Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 889–897, Nicolas Dzamko, Dominic B. Rowe and Glenda M. Halliday

    Version of Record online : 25 FEB 2016, DOI: 10.1002/mds.26529

  4. Low-variance RNAs identify Parkinson's disease molecular signature in blood

    Movement Disorders

    Volume 30, Issue 6, May 2015, Pages: 813–821, Maria D. Chikina, Christophe P. Gerald, Xianting Li, Yongchao Ge, Hanna Pincas, Venugopalan D. Nair, Aaron K. Wong, Arjun Krishnan, Olga G. Troyanskaya, Deborah Raymond, Rachel Saunders-Pullman, Susan B. Bressman, Zhenyu Yue and Stuart C. Sealfon

    Version of Record online : 18 MAR 2015, DOI: 10.1002/mds.26205

  5. You have full text access to this OnlineOpen article
    Ten Years and Counting: Moving Leucine-Rich RepeatKinase 2 Inhibitors to the Clinic

    Movement Disorders

    Volume 30, Issue 2, February 2015, Pages: 180–189, Andrew B. West

    Version of Record online : 1 DEC 2014, DOI: 10.1002/mds.26075

  6. Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutations

    Movement Disorders

    Volume 30, Issue 7, June 2015, Pages: 904–908, Claustre Pont-Sunyer, Susan Bressman, Deborah Raymond, Amanda Glickman, Eduardo Tolosa and Rachel Saunders-Pullman

    Version of Record online : 7 MAY 2015, DOI: 10.1002/mds.26250

  7. Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutations

    Movement Disorders

    Volume 28, Issue 14, December 2013, Pages: 1966–1971, Roy N. Alcalay, Anat Mirelman, Rachel Saunders-Pullman, Ming-X Tang, Helen Mejia Santana, Deborah Raymond, Ernest Roos, Martha Orbe-Reilly, Tanya Gurevich, Anat Bar Shira, Mali Gana Weisz, Kira Yasinovsky, Maayan Zalis, Avner Thaler, Andres Deik, Matthew James Barrett, Jose Cabassa, Mark Groves, Ann L. Hunt, Naomi Lubarr, Marta San Luciano, Joan Miravite, Christina Palmese, Rivka Sachdev, Harini Sarva, Lawrence Severt, Vicki Shanker, Matthew Carrington Swan, Jeannie Soto-Valencia, Brooke Johannes, Robert Ortega, Stanley Fahn, Lucien Cote, Cheryl Waters, Pietro Mazzoni, Blair Ford, Elan Louis, Oren Levy, Llency Rosado, Diana Ruiz, Tsvyatko Dorovski, Michael Pauciulo, William Nichols, Avi Orr-Urtreger, Laurie Ozelius, Lorraine Clark, Nir Giladi, Susan Bressman and Karen S. Marder

    Version of Record online : 15 OCT 2013, DOI: 10.1002/mds.25647

  8. Cognitive profile of LRRK2-related Parkinson's disease

    Movement Disorders

    Volume 30, Issue 5, 15 April 2015, Pages: 728–733, Sindhu Srivatsal, Brenna Cholerton, James B. Leverenz, Zbigniew K. Wszolek, Ryan J. Uitti, Dennis W. Dickson, Daniel Weintraub, John Q. Trojanowski, Vivianna M. Van Deerlin, Joseph F. Quinn, Kathryn A. Chung, Amie L. Peterson, Stewart A. Factor, Cathy Wood-Siverio, Jennifer G. Goldman, Glenn T. Stebbins, Bryan Bernard, Beate Ritz, Rebecca Rausch, Alberto J. Espay, Fredy J. Revilla, Johnna Devoto, Liana S. Rosenthal, Ted M. Dawson, Marilyn S. Albert, Ignacio F. Mata, Shu-Ching Hu, Kathleen S. Montine, Catherine Johnson, Thomas J. Montine, Karen L. Edwards, Jing Zhang and Cyrus P. Zabetian

    Version of Record online : 4 FEB 2015, DOI: 10.1002/mds.26161

  9. Nigral and striatal connectivity alterations in asymptomatic LRRK2 mutation carriers: A magnetic resonance imaging study

    Movement Disorders

    Dolores Vilas, Bàrbara Segura, Hugo C. Baggio, Claustre Pont-Sunyer, Yaroslau Compta, Francesc Valldeoriola, María José Martí, María Quintana, Angels Bayés, Jorge Hernández-Vara, Matilde Calopa, Miquel Aguilar, Carme Junqué, Eduardo Tolosa and and the Barcelona LRRK2 Study Group

    Version of Record online : 21 SEP 2016, DOI: 10.1002/mds.26799

  10. Arm swing as a potential new prodromal marker of Parkinson's disease

    Movement Disorders

    Anat Mirelman, Hagar Bernad-Elazari, Avner Thaler, Eytan Giladi-Yacobi, Tanya Gurevich, Mali Gana-Weisz, Rachel Saunders-Pullman, Deborah Raymond, Nancy Doan, Susan B. Bressman, Karen S. Marder, Roy N. Alcalay, Ashwini K. Rao, Daniela Berg, Kathrin Brockmann, Jan Aasly, Bjørg Johanne Waro, Eduardo Tolosa, Dolores Vilas, Claustre Pont-Sunyer, Avi Orr-Urtreger, Jeffrey M. Hausdorff and Nir Giladi

    Version of Record online : 19 JUL 2016, DOI: 10.1002/mds.26720

  11. DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease

    Movement Disorders

    Volume 31, Issue 3, March 2016, Pages: 335–343, Alberto Bergareche, Maria Cruz Rodríguez-Oroz, Ainara Estanga, Ana Gorostidi, Adolfo López de Munain, Tamara Castillo-Triviño, Javier Ruiz-Martínez, Elisabet Mondragón, Carles Gaig, Francisco Lomeña, Cristina Sarasqueta, Eduardo Tolosa and José Félix Martí-Massó

    Version of Record online : 21 DEC 2015, DOI: 10.1002/mds.26478

  12. Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation

    Movement Disorders

    Volume 28, Issue 12, October 2013, Pages: 1683–1690, Anat Mirelman, Talia Heman, Kira Yasinovsky, Avner Thaler, Tanya Gurevich, Karen Marder, Susan Bressman, Anat Bar-Shira, Avi Orr-Urtreger, Nir Giladi, Jeffrey M. Hausdorff and on behalf of the LRRK2 Ashkenazi Jewish Consortium

    Version of Record online : 7 OCT 2013, DOI: 10.1002/mds.25587

  13. REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers

    Movement Disorders

    Volume 30, Issue 13, November 2015, Pages: 1834–1839, Rachel Saunders-Pullman, Roy N. Alcalay, Anat Mirelman, Cuiling Wang, Marta San Luciano, Roberto A. Ortega, Amanda Glickman, Deborah Raymond, Helen Mejia-Santana, Nancy Doan, Brooke Johannes, Kira Yasinovsky, Laurie Ozelius, Lorraine Clark, Avi Orr-Utreger, Karen Marder, Nir Giladi, Susan B. Bressman and the AJ LRRK2 Consortium

    Version of Record online : 14 SEP 2015, DOI: 10.1002/mds.26413

  14. A voxel-based morphometry and diffusion tensor imaging analysis of asymptomatic Parkinson's disease-related G2019S LRRK2 mutation carriers

    Movement Disorders

    Volume 29, Issue 6, May 2014, Pages: 823–827, Avner Thaler, Moran Artzi, Anat Mirelman, Yael Jacob, Rick C. Helmich, Bart F.L. van Nuenen, Tanya Gurevich, Avi Orr-Urtreger, Karen Marder, Susan Bressman, Bastiaan R. Bloem, Talma Hendler, Nir Giladi, Dafna Ben Bashat and the LRRK2 Ashkenazi Jewish Consortium

    Version of Record online : 30 JAN 2014, DOI: 10.1002/mds.25827

  15. Early synaptic dysfunction in Parkinson's disease: Insights from animal models

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 802–813, Tommaso Schirinzi, Graziella Madeo, Giuseppina Martella, Marta Maltese, Barbara Picconi, Paolo Calabresi and Antonio Pisani

    Version of Record online : 19 MAY 2016, DOI: 10.1002/mds.26620

  16. Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease

    Movement Disorders

    Kyle B. Fraser, Ashlee B. Rawlins, Rachel G. Clark, Roy N. Alcalay, David G. Standaert, Nianjun Liu, Parkinson's Disease Biomarker Program Consortium and Andrew B. West

    Version of Record online : 14 JUN 2016, DOI: 10.1002/mds.26686

  17. Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene

    Movement Disorders

    Volume 30, Issue 7, June 2015, Pages: 981–986, Anat Mirelman, Roy N. Alcalay, Rachel Saunders-Pullman, Kira Yasinovsky, Avner Thaler, Tanya Gurevich, Helen Mejia-Santana, Deborah Raymond, Mali Gana-Weisz, Anat Bar-Shira, Laurie Ozelius, Lorraine Clark, Avi Orr-Urtreger, Susan Bressman, Karen Marder, Nir Giladi and the LRRK2 AJ consortium

    Version of Record online : 21 MAR 2015, DOI: 10.1002/mds.26213

  18. Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease

    Movement Disorders

    Volume 30, Issue 7, June 2015, Pages: 945–952, Gabriel Castellanos, María A. Fernández-Seara, Oswaldo Lorenzo-Betancor, Sara Ortega-Cubero, Marc Puigvert, Javier Uranga, Marta Vidorreta, Jaione Irigoyen, Elena Lorenzo, Arrate Muñoz-Barrutia, Carlos Ortiz-de-Solorzano, Pau Pastor and María A. Pastor

    Version of Record online : 15 MAR 2015, DOI: 10.1002/mds.26201

  19. Motor progression of Parkinson's disease with the leucine-rich repeat kinase 2 G2019S mutation

    Movement Disorders

    Volume 29, Issue 8, July 2014, Pages: 1057–1060, Gilad Yahalom, Yael Orlev, Oren S. Cohen, Evgenia Kozlova, Eitan Friedman, Rivka Inzelberg and Sharon Hassin-Baer

    Version of Record online : 5 JUN 2014, DOI: 10.1002/mds.25931

  20. The genetics of Parkinson's disease: Progress and therapeutic implications

    Movement Disorders

    Volume 28, Issue 1, January 2013, Pages: 14–23, Andrew B. Singleton, Matthew J. Farrer and Vincenzo Bonifati

    Version of Record online : 6 FEB 2013, DOI: 10.1002/mds.25249